Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

A survey on the practices and the management of hemorrhagic cystitis in patients who undergo allogeneic hematopoietic stem cell transplantation, on behalf of the Infectious Diseases Working Party of EBMT

Abstract

This survey reports on the current practice and management of hemorrhagic cystitis (HC) among the EBMT centers. The survey response rate was 27%. The diagnostic search of BK polyomavirus (BKPyV) was available in 93% of centers and performed in urine (100%), blood/plasma (51%), and serum (12%). Patient screening for BKPyV infection was performed in 14% of centers before hematopoietic cell transplantation (HCT). In comparison, surveillance for BKPyV infection was performed after HCT in 39% of centers, mainly with a frequency of 1–2 times/week. Preventative measures are based mainly on hyperhydration and sodium 2-mercaptoethanesulphonate (Mesna), while the use of bladder catheter is limited; moreover, 23% of centers used quinolones prophylaxis.The primary therapeutic interventions are hyperhydration, Mesna, analgesics, and sustained platelet transfusions; bladder irrigation by urinary catheter is adopted by 47–50% of centers. In the case of BKPyV infection, 85% of centers use intravenous or intrabladder administration of cidofovir at a dosage ranging from 1 to 5 mg/kg. Centers report a miscellaneous range of alternative therapeutic measures (adoptive immunotherapy, hyperbaric oxygen therapy, fibrin glue/platelet-rich plasma, leflunomide, sodium hyaluronate) and the need for invasive procedures. This survey confirms that the management of HC needs further education, clinical research, and innovation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Data availability

The datasets generated and analyzed during the current study are available from the corresponding author on reasonable request after approval of the scientific board of The Infectious Diseases Working Party of EBMT.

References

  1. Cesaro S, Dalianis T, Hanssen Rinaldo C, Koskenvuo M, Pegoraro A, Einsele H, et al. ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients. J Antimicrob Chemother. 2018;73:12–21.

    CAS  PubMed  Google Scholar 

  2. Saade A, Styczynski J, Cesaro S. Infectious Disease Working party of EBMT. BK virus infection in allogeneic hematopoietic cell transplantation: An update on pathogenesis, immune responses, diagnosis and treatments. J Infect. 2020;81:372–82.

    Article  CAS  PubMed  Google Scholar 

  3. Saade A, Gras J, Darmon M, Michonneau D, Dhedin N, Feghoul L, et al. Incidence, risk factors and outcome of BK virus hemorrhagic cystitis following allogenic hematopoietic cell transplantation: a retrospective cohort study. Bone Marrow Transpl. 2022;57:1287–94.

    Article  CAS  Google Scholar 

  4. Zhang S, Liu M, Wang Q, Wang S, Liu X, Li B, et al. Risk factors for hemorrhagic cystitis in children undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis. BMC Pediatr. 2024;24:333.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Lunde LE, Dasaraju S, Cao Q, Cohn CS, Reding M, Bejanyan N, et al. Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival. Bone Marrow Transpl. 2015;50:1432–7.

    Article  CAS  Google Scholar 

  6. Chorão P, Villalba M, Balaguer-Roselló A, Montoro J, Granados P, Gilabert C, et al. Incidence, risk factors, and outcomes of BK hemorrhagic cystitis in hematopoietic stem cell transplantation from HLA-matched and haploidentical donors with post-transplant cyclophosphamide. Transplant Cell Ther. 2025;31:182.e1–182.e11.

    Article  PubMed  Google Scholar 

  7. Merchán-Muñoz B, Suárez-Lledó M, Rodríguez-Lobato LG, Aiello TF, Gallardo-Pizarro A, Charry P, et al. Post-transplant cyclophosphamide-based prophylaxis and its impact on infectious complications and immune reconstitution according to donor type. Cancers. 2025;17:1109.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Leung AYH, Yuen K-Y, Kwong Y-L. Polyoma BK virus and haemorrhagic cystitis in haematopoietic stem cell transplantation: a changing paradigm. Bone Marrow Transpl. 2005;36:929–37.

    Article  CAS  Google Scholar 

  9. Schneidewind L, Neumann T, Kranz J, Knoll F, Pelzer AE, Schmidt C, et al. Nationwide survey of BK polyomavirus associated hemorrhagic cystitis in adult allogeneic stem cell transplantation among haematologists and urologists. Ann Hematol. 2017;96:797–803.

    Article  PubMed  Google Scholar 

  10. Mohammadi Najafabadi M, Soleimani M, Ahmadvand M, Soufi Zomorrod M, Mousavi SA. Treatment protocols for BK virus associated hemorrhagic cystitis after hematopoietic stem cell transplantation. Am J Blood Res. 2020;10:217–30.

    PubMed  PubMed Central  Google Scholar 

  11. Dell’Orso G, Carlucci M, Cesaro S, Olcese E, Balduzzi A, Vendemini F, et al. An expert consensus on prevention, diagnosis, and management of hemorrhagic cystitis in pediatric hematopoietic cell transplantation, on behalf of the Infectious Disease and Hematopoietic Cell Transplant Working groups of Italian Pediatric Hematology Oncology Association (AIEOP). Bone Marrow Transpl. 2024;59:1302–8.

    Article  Google Scholar 

  12. Cesaro S, Ljungman P, Tridello G, Mikulska M, Wendel L, Styczynski J, et al. New trends in the management of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a survey of the Infectious Diseases Working Pary of EBMT. Bone Marrow Transpl. 2023;58:203–8.

    Article  CAS  Google Scholar 

  13. Cesaro S, Berger M, Tridello G, Mikulska M, Ward KN, Ljungman P, et al. A survey on incidence and management of adenovirus infection after allogeneic HSCT. Bone Marrow Transpl. 2019;54:1275–80.

    Article  Google Scholar 

  14. Styczynski J, Tridello G, Wendel L, Knelange N, Cesaro S, Gil L, et al. Prevalence, management, and new treatment modalities of EBV-DNA-emia and EBV-PTLD after allo-HCT: survey of Infectious Diseases Working Party EBMT. Bone Marrow Transpl. 2024;59:59–65.

    Article  CAS  Google Scholar 

  15. Bedi A, Miller CB, Hanson JL, Goodman S, Ambinder RF, Charache P, et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol. 1995;13:1103–9.

    Article  CAS  PubMed  Google Scholar 

  16. Leung AYH, Chan MTL, Yuen K-Y, Cheng VCC, Chan K-H, Wong CLP, et al. Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation. Clin Infect Dis. 2005;40:528–37.

    Article  CAS  PubMed  Google Scholar 

  17. Miller AN, Glode A, Hogan KR, Schaub C, Kramer C, Stuart RK, et al. Efficacy and safety of ciprofloxacin for prophylaxis of polyomavirus BK virus-associated hemorrhagic cystitis in allogeneic hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transpl. 2011;17:1176–81.

    Article  CAS  Google Scholar 

  18. Ito Y, Hino T, Honda A, Kurokawa M. Fluoroquinolones for BK viral complication after transplantation: meta-analysis. Transpl Infect Dis. 2020;22:e13433.

    Article  CAS  PubMed  Google Scholar 

  19. Albalawi MAH, Al-Sayaghi KM, Hegazy SM, Merghani MM, Osman NM, Abdelmagid LO, et al. Prophylactic fluoroquinolones in hematopoietic stem cell transplant recipients: A meta-analytic comparison of ciprofloxacin and levofloxacin. Medicine. 2025;104:e42317.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Er AG, Aslan AT, Mikulska M, Akova M. Prevention and treatment of bacterial infections in patients with haematological cancers and haematopoietic stem cell transplantation: headways and shortcomings. Clin Microbiol Infect. 2025;31:24–28.

    Article  PubMed  Google Scholar 

  21. Samuels DT, Yao JM, Samara Y, Yang D, Mokhtari S, Tiemann K, et al. Impact of hyperhydration on fluid overload and hematopoietic cell transplant after post-transplant cyclophosphamide-based graft-versus-host-disease prophylaxis. Front Immunol. 2025;16:1543099.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Tooker GM, Stafford KA, Nishioka J, Badros AZ, Riedel DJ. Intravesicular cidofovir in the treatment of BK virus-associated hemorrhagic cystitis following hematopoietic stem cell transplantation. Ann Pharmacother. 2020;54:547–53.

    Article  CAS  PubMed  Google Scholar 

  23. Foster JH, Cheng WS, Nguyen N-Y, Krance R, Martinez C. Intravesicular cidofovir for BK hemorrhagic cystitis in pediatric patients after hematopoietic stem cell transplant. Pediatr Transpl. 2018;22:e13141.

    Article  Google Scholar 

  24. Schneidewind L, Neumann T, Schmidt CA, Krüger W. Comparison of intravenous or intravesical cidofovir in the treatment of BK polyomavirus-associated hemorrhagic cystitis following adult allogeneic stem cell transplantation-a systematic review. Transpl Infect Dis. 2018;20:e12914.

    Article  PubMed  Google Scholar 

  25. Tirindelli MC, Flammia GP, Bove P, Cerretti R, Cudillo L, De Angelis G, et al. Fibrin glue therapy for severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2014;20:1612–7.

    Article  CAS  Google Scholar 

  26. Arana Ribeiro J, Alpuim Costa D, Gaio-Lima C, Guilherme Gonçalves-Nobre J, Portugal Rodrigues I, Trigo Miranda M, et al. Hyperbaric oxygen therapy in the treatment of late-onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation. Sci Rep. 2024;14:24658.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Masieri L, Sessa F, Mari A, Campi R, Cito G, Verrienti P, et al. Intravesical application of platelet-rich plasma in patients with persistent haemorrhagic cystitis after hematopoietic stem cell transplantation: a single-centre preliminary experience. Int Urol Nephrol. 2019;51:1715–20.

    Article  CAS  PubMed  Google Scholar 

  28. Tzannou I, Papadopoulou A, Naik S, Leung K, Martinez CA, Ramos CA, et al. Off-the-shelf virus-specific T cells to treat BK virus, human herpesvirus 6, cytomegalovirus, epstein-barr virus, and adenovirus infections after allogeneic hematopoietic stem-cell transplantation. J Clin Oncol. 2017;35:3547–57.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Koldehoff M, Eiz-Vesper B, Maecker-Kolhoff B, Steckel NK, Dittmer U, Horn PA, et al. Long-term follow-up after adoptive transfer of BK-virus-specific T cells in hematopoietic stem cell transplant recipients. Vaccines. 2023;11:845.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Cesaro S, Tridello G, Pillon M, Calore E, Abate D, Tumino M, et al. A prospective study on the predictive value of plasma BK virus-DNA load for hemorrhagic cystitis in pediatric patients after stem cell transplantation. J Pediatr Infect Dis Soc. 2015;4:134–42.

    Article  Google Scholar 

  31. Moss JE, Muller WJ. BK virus-associated hemorrhagic cystitis in pediatric stem cell transplantation: a case report and scoping review. Front Pediatr. 2023;11:1267678.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We acknowledge all EBMT centers participating to the survey. The centers are listed according to their identification code (CIC), principal investigator’s name, study reporter’s name, city, and country. CIC 104, Mathias Haenel and Simone Karp, Chemnitz, Germany; CIC 141 Domenico Russo and Gabriele Magliano, Brescia, Italy; CIC 145, Martin Kaufmann and Sandra Siegle, Stuttgart, Germany; CIC 159, Mohammed Marei and Hassan Alshehri, Riyadh, Saudi Arabia; CIC 161, Ron Ram, Tel Aviv, Israel; CIC 163, Daniele Vallisa, Piacenza, Italy; CIC 177, Oleksandr Lysytsia, Kyiv, Ukraine; CIC 188, Mani Ramzi, Shiraz, Iran; CIC 197, Astrid Olsnes Kittang, Bergen, Norway; CIC 202, Jacob Passweg and Nina Khanna, Basel, Switzerland; CIC 204, Elisa Sala, Ulm, Germany; CIC 207, Regis Peffault de Latour and Alienor Xhaard, Paris, France; CIC 209, Johan Maertens, Leuven, Belgium; CIC 217, Emanuele Angelucci and Malgorzata Mikulska, Genova, Italy; CIC 225, Maija Itala-Remes, Turku, Finland; CIC 227, Werner Rabitsch, Vienna, Austria; CIC 232, Anna Paola Iori, Rome, Italy; CIC 242, Arancha Bermudez Rogriguez and Guillermo Martin-Sanchez, Santander, Spain; CIC 245, Lucia Prezioso, Parma, Italy; CIC 246, Annoek Broers, Rotterdam, The Netherlands; CIC 250, Jerome Cornillon, Saint Etienne, France; CIC 252, Romain Gounot and Christine Robin, Creteil, France; CIC 254, Jennifer Clay, Leeds, United Kingdom; CIC 256, Friedrich Stolzel, Kiel, Germany; CIC 257, Catherine Flynn, Dublin, Ireland; CIC 260, Rodrigo Martino Bufarull and Albert Esquirol, Barcelona, Spain; CIC 261, Yves Chaladon and Dionysios Neofytos, Geneva, Switzerland; CIC 264, Xavier Leleu and Natacha Maillard, Poitiers, France; CIC 266, Kristina Carlson, Uppsala, Sweden; CIC 267, Edouard Forcade, Pessac, France; CIC 270, Claude Eric Bulabois, Grenoble, France; CIC 272, Emmanuel Gyan and Alban Villate, Tours, France; CIC 274, Maura Faraci, Genova, Italy; CIC 277, Ibrahim Yakoub-Agha and Valerie Coiteux, Lille, France; CIC 282, Carlos Solano Vercet and Jose Luis Pinana, Valencia, Spain; CIC 283, Stig Lenhoff, Lund, Sweden; CIC 287, Anna Proia, Rome, Italy; CIC 297, Gesine Bug, Frankfurt, Germany; CIC 300, Fernando Leal da Costa and Nuno Miranda, Lisboa, Portugal; CIC 304, Chiara Nozzoli and Ilaria Cutini, Firenze, Italy; CIC 307, Simona Sica and Elisabetta Metafuni, Rome, Italy; CIC 346, Boryana Avramova and Irena Vlahova, Sofia, Bulgaria; CIC 348, Edgar Jost, Aachen, Germany; CIC 352, Marc Bierings, Utrecht, The Netherlands, CIC 355, Serdar Bedii Omay and Yakup Unsal, Istanbul, Turkey; CIC 358, Dragana Vujic, Belgrade, Sofia; CIC 367, Friederike Wortmann, Luebeck, Germany; CIC 381, Borce Georgievski and Zlate Stojanoski, Skopje, North Macedonia; CIC 382, Joaquin Martinez Lopez and Maria Calbacho, Madrid, Spain; CIC 386, Caroline Besley, Bristol, United Kingdom; CIC 392, Luca Castagna, Palermo, Italy; CIC 397, Mahmoud Aljurf, Riyadh, Saudi Arabia; CIC 399, Duygu Uckan-Cetinkaya and Baris Kuskonmaz, Ankara, Turkey; CIC 401, Huang He, Hangzhou, China; CIC 409, Moshe Yeshurun, Petach-Tikva, Israel; CIC 415, Marta Stanzani, Treviso, Italy; CIC 427, Alina Tanase and Lipan Lavinia, Bucharest, Romania; CIC 428, Sebastian Giebel and Malgorzata Sobczyk-Kruszelnicka, Gliwice, Poland; CIC 434, Aloysius Ho, Singapore, Singapore; CIC 444, Mohsen Al Zahrani, Riyadh, Saudi Arabia; CIC 445, Leylagul Kaynar and Bilge Unal, Istanbul, Turkey; CIC 448, Tunc Fisgin and Rabia Taskale, Istanbul, Turkey; CIC 451, Trancisco Cuellar-Ambrosi, Medellin, Colombia; CIC 454, Ali Bulent Antmen, Adana, Turkey; CIC 459, Baris Malbora, Istanbul, Turkey; CIC 465, Rajat Argawal, Bangalore, India; CIC 468, Siret Ratip and Aysem Kuni, Istanbul, Turkey; CIC 505, Birgit Burkhardt and Andreas Groll, Muenster, Germany; CIC 515, Urpu Salmenniemi, Helsinki, Finland; CIC 525, Natalia Maximova, Trieste, Italy; CIC 528, Herbert Pichler, Vienna, Austria; CIC 535, Peter Lang, Tuebingen, Germany; CIC 537, Maria del Mar Perera Alvarez and Maria Melania Moreno Vega, Las Palmas, Spain; CIC 538, Jaroslaw Dybko, Wroclaw, Poland; CIC 539, Mickey Koh and Sara Lozano Cerrada, London, United Kingdom; CIC 546, Goda Choi and Jaap van Doesum, Groningen, The Netherlands; CIC 561, Ioanna Sakellari, Thessaloniki, Greece; CIC 565, Gwendolyn van Gorkom, Maastricht, The Netherlands; CIC 576, Maria Jesus Pascual Cascon, Malaga, Spain; CIC 577, Teresa Zudaire, Pamplona, Spain; CIC 580, Khaled Halahleh, Amman, Jordan; CIC 583, Ilze Trociukas and Sara Krustina, Riga, Latvia; CIC 584, David Valcarcel, Barcelona, Spain; CIC 587, Massimo Martino, Reggio Calabria, Italy; CIC 589, Hakan Ozdogu, Adana Turkey; CIC 598, Carlos Manuel Panizo Santos and Maria Cruz Viguria Alegria, San Sebastian, Spain; CIC 599, Agnes Kelemen, Miskolc, Hungary; CIC 606, Nicola Mordini, Cuneo, Italy; CIC 607, Alessandra Picardi, Napoli, Italy; CIC 614, Nicolaus Kroeger and Dietlinde Janson, Hamburg, Germany; CIC 622, Ioannis Baltadakis, Athens, Greece; CIC 623, Cristina Tecchio, Verona, Italy; CIC 628, Filiz Vural, Izmir, Turkey; CIC 629, Tariq Ghafoor and Raheel Iftikhar, Rawalpindi, Pakistan; CIC 634, Gitte Olesen, Aarhus, Denmark; CIC 640, Matjaz Sever and Njetocka Gredelj, Ljubljana, Slovenia; CIC 650, Mathilde Hunault-Berger and Sylvie Francois, Angers, France; CIC 653, Jose Maria Fernandez Navarro, Valencia, Spain; CIC 656, Jan Vydra, Prague, Czech Republic; CIC 658, Alessandro Rambaldi, Bergamo, Italy; CIC 660, Francesco Merli and Luca Facchini, Reggio Emilia, Italy; CIC 663, Jaime Sanz Caballer and Pedro Chorao, Valencia Spain; CIC 670, Ronit Elhasid and Amit Dotan, Tel Aviv, Israel; CIC 671, Helene Labussiere-Wallet, Lyon, France; CIC 677, Grzegorz Helbig, Katowice, Poland; CIC 693, Kazimierz Halaburda and Barbara Nasilowska-Adamska, Warsaw, Poland; CIC 717, Jennifer Byrne, Nottingham, United Kingdom; CIC 732 Marta Gonzalez Vicent, Madrid, Spain; CIC 734, Antonio Perez-Martinez and Yasmina Mozo, Madrid, Spain; CIC 737, Jose Rifon, Pamplona, Spain; CIC 741, Fulvio Porta and Elena Soncini, Brescia, Italy; CIC 749, Lisa Pospiech and Jochen Casper, Oldenburg, Germany; CIC 755, Jerry Stein, Petach-Tikva, Israel; CIC 759, Alberto Mussetti, Barcelona, Spain; CIC 761, Muhlis Cem Ar and Tugrul Elverdi, Istanbul, Turkey; CIC 764, Jan Styczynski, Bydgoszcz, Poland; CIC 769, Jose Antonio Perez-Simon and Juan Alberto Martin Gonzalez, Sevilla, Spain; CIC 786, Eva Wagner-Drouet, Mainz, Germany; CIC 790, Arcangelo Prete, Bologna, Italy; CIC 795, Edoardo Benedetti and Ginevra Traverso, Pisa, Italy; CIC 799, Jan Zaucha and Agnieszka Piekarska, Gdansk, Poland; CIC 811, Giorgio La Nasa and Eugenia Piras, Cagliari, Italy; CIC 817, Krzysztof Kalwak and Jowita Fraczkiewicz, Wroclaw, Poland; CIC 824, Gergely Krivan and Csaba Kassa, Budapest, Hungary; CIC 825, Francesco Zallio, Alessandria, Italy; CIC 856, Amir Ali Hamidieh and Maryam Behfar, Teheran, Iran; CIC 859, Andriyana Bankova and Krasen Venkov, Sofia, Bulgaria; CIC 861, Michele Cimminiello, Potenza, Italy; CIC 868, Nicola Di Renzo and Vincenzo Federico, Lecce, Italy; CIC 911, Akif Yesilipek and Vedat Uygun, Antalya, Turkey; CIC 913, Musa Karakukcu, Kayseri, Turkey; CIC 919, Yener Koc, Istanbul, Turkey; CIC 926, Anne Sirvent and Jean-Jacques Tudesq, Montpellier, France; CIC 928, Carmine Selleri and Denise Morini and Bianca Serio, Salerno, Italy; CIC 933, Katharine Patrick, Sheffield, United Kingdom; CIC 981, Ali AlAhmari and Syed Jafri, Riyadh, Saudi Arabia; CIC 1001, Cigdem Ozturk, Muharraq Bahrain; CIC 1004, Ibrahim Eker, Afyonkarahisar, Turkey; CIC 1006, Marco Zecca, Pavia, Italy; CIC 1012, Jiong Hu, Shanghai, China; CIC 1032, Baodong Ye, Hangzhou China; CIC 1035, Galina Petrova, Moscow, Russia; CIC 1041, Sondus Alsharidah and Zoha Muneer Zubairi, Al-Sabah, Kuwait; CIC 1042, Juan Manual Herrera Parga and Oscar Ramirez, Cali, Colombia; CIC 1050, Andres Castaneda, Santiago and Hernan Lopez Vidal, Chile; CIC 1058, Rawad Rihani and Hasan Hashem, Amman, Jordan; CIC 1059, Mauricio Chaparro, Bogota, Colombia; CIC 1064, Rahul Bhargava and Neha Rastogi, Gurugram, India; CIC 1067, Fawaz Faddo, Baghdad, Iraq; CIC 1072, Hayder Alzughair and Ahmed Hamandi, Karbala, Iraq; CIC 1073, Jian Hou and Lijing Sheng, Shanghai, China; CIC 1074, Daihong Liu and Yao Sun, Beijing, China; CIC 1077, Dwi Wahyunianto Hadisantoso, Jakarta, Indonesia.

Author information

Authors and Affiliations

Authors

Contributions

SC designed and conducted the study; DA, ZP, RDLC, and JS, critically revised the design of the survey; IV collected the data; GT and SC analyzed the data; SC wrote the manuscript; SC, JS, WHMR, AH, MS, YP, NBA, PM, IZ, FPT, SE, MV, JMR, MK, LLC, EG, RC, KP, MH, MW, AN, AB, MS, ASS, SB, CB, CS, JG, AC, MHM, MP, AdB, DR, ZP, RDLC, and DA reported the data. All authors critically revised the manuscript and approved the final version of the manuscript.

Corresponding author

Correspondence to Simone Cesaro.

Ethics declarations

Competing interests

SE received honoraria from Novartis and Gilead; MP received honoraria from Kite and Bristol Myers Squibb for participation in advisory boards; DA received speaker’s honoraria from MSD. All other authors declare no conflict of interest to disclose.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cesaro, S., Verheggen, I., Tridello, G. et al. A survey on the practices and the management of hemorrhagic cystitis in patients who undergo allogeneic hematopoietic stem cell transplantation, on behalf of the Infectious Diseases Working Party of EBMT. Bone Marrow Transplant (2025). https://doi.org/10.1038/s41409-025-02703-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41409-025-02703-1

Search

Quick links